News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Data analysis of the DNA, RNA, protein, and phosphoprotein in lung adenocarcinoma cells connected molecular features of tumors with patient survivability. This study allowed researchers to better predict prognosis and treatment in lung cancer patients.

The latest update to the Childhood Cancer Data Catalog includes website improvements and the addition of the database of Genotypes and Phenotypes (dbGaP).

Discover how researchers are using NIH/NCI genomics and proteomics data to gain insight into chemotherapy resistance in triple negative breast cancer.

Celebrate the NCI team that recently received a 2022 FedHealthIT Innovation Award for their commitment to advancing cancer research through work proteomics efforts such as the Proteomic Data Commons.

If you’re attending the 2022 American Association for Cancer Research Annual Meeting (either in person or virtual), don’t miss these data science sessions, poster presentations, and the NCI exhibit booth, where you can hear more about our programs and activities!

CBIIT Director, Dr. Tony Kerlavage, sat down recently for a podcast examining the evolution of NCI’s Data Commons. He tracked the development of the Cancer Research Data Commons, from its early pilots to today’s cloud-based infrastructure, with repositories of diverse data and more than 1,000 tools and resources.

The NCI Cancer Research Data Commons has recently added 1,000 new clinical outcome data files for Clinical Proteomic Tumor Atlas Consortium (CPTAC) studies to NCI’s Genomic Data Commons and Proteomic Data Commons.

Supplementary proteomics data from the most comprehensive molecular map of lung squamous cell carcinoma (LSCC) is available in the NCI Proteomics Data Commons (PDC).

Attending the second week of the 2021 American Association for Cancer Research (AACR) Annual Meeting? Here are a few event sessions you won’t want to miss to learn more about the latest NCI data science, data commons, and cancer research activities.

Clinical Proteomic Tumor Analysis Consortium (CPTAC) researchers from the Nesvizhskii Lab at the University of Michigan have developed an extension of its MSFragger flagship software to identify N- and O-linked glycopeptides.